chronic kidney diseases is expected to drive the global kidney function test market at an approximate CAGR of 6.20% during the forecast period :

Pune, India, June 2022/MRFR Press Release/- Market Research Future published a half-cooked research report on the global kidney function test market.


Market Highlights


The Kidney Function Test Market is anticipated to reach USD 795.4 Million by 2030 at 6.20% CAGR during the forecast period 2022-2030.


The increasing prevalence of chronic kidney diseases, increase in alcohol consumption, change to sedentary lifestyle, growing prevalence of diabetes, rising obesity and increasing prevalence of cardiovascular diseases are the key factors for the market to grow. However, factors such as high cost of diagnostic procedures, infections, and huge initial investments are expected to restrict the market growth during the forecast period.


Segmentation


The global kidney function test market is segmented on the basis of tests, product, and end-user. The kidney function test market, by tests categorized into blood tests, imaging tests, urine tests balloons and kidney biopsy. Blood tests category includes serum creatinine, glomerular filtration rate (GFR), and blood urea nitrogen (BUN). The imaging tests segment includes ultrasound and CT scan. The urine tests category includes urinalysis, urine protein, microalbuminuria, and creatinine clearance. The product segment is segmented into dipsticks, disposables, and reagents. On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic laboratories, ambulatory surgical centers, academic research laboratories, and others.     


Explore In-depth Details: Kidney Function Test Market Research Report


Regional Analysis


The Americas is expected to dominate the kidney function test market during the forecast period. The rise in the occurrence of chronic kidney diseases drives the market in this region. According to the Centers for Disease Control and Prevention (2017), 30 million Americans are affected by Chronic Kidney Disease. It is also mentioned that CKD is more prevalent in women than in men. This influences the market growth during the forecast period.  


Europe (U.K., Belgium, France, and the Netherlands) is second in the market owing to the increasing prevalence of diabetes and growing healthcare expenditure. According to the World Health Organization 2015, 60 million people in Europe are affected by diabetes. High prevalence of diabetes drives the market growth in this region.


Asia Pacific is expected to observe growth in the global kidney function test market owing to increasing prevalence of diabetes, rising geriatric population, high blood pressure, and change to an unhealthy lifestyle. High blood pressure damages the blood vessels of the kidney which eventually leads to improper functioning of the kidney. According to the Blood Pressure Association in 2015, large patient pool with high blood pressure was found in South Asia with 226 million people in China and 199 million in India. This provides favorable backgrounds for the market growth.


The Middle East and Africa accounts for the least share due to stringent government policies and low national income.


Key Players


Some of the key players for the global kidney function test market are Urit Medical, Sysmex Corporation, Siemens Healthcare GmbH (Germany), F. Hoffmann-La Roche Ltd,  Randox Laboratories, Opti Medical, Nova Biomedical, Beckman Coulter, ARKRAY, Inc., Acon Laboratories, Abbott, 77 Elektronika, Medical Care (Germany), Baxter (U.S.), Boston Scientific (U.S.), and others.